As a conclusion, long-term therapy of NAFLD complicated by T2DM utilizing SGLT-2 inhibitors is able to improve the liver histopathology although clinical features might be worsened [223]. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.